PROGRAM INFORMATION · Programs are not accepting patients yet
iWellnissLONGEVITY
MEDICAL & TREATMENT INFORMATION

Informed choices.
Individual care.

This information accompanies the program pages. Enrollment, prescribing and checkout are not active in this website.

Medical evaluation comes first

Program information is educational and describes intended goals and biological rationale, not a diagnosis, personal recommendation or promise of benefit. A licensed clinician must review your history, medications, contraindications and alternatives and decide whether any treatment is appropriate. A prescription is required where applicable; purchasing intent never guarantees a prescription.

Evidence, approval and compounding

Mechanisms, animal studies, cell studies and changes in laboratory markers do not establish clinical benefits for a program. Evidence for an individual ingredient cannot be assumed to apply to a combination, another route, dose or formulation.

Compounded medications are not FDA-approved. FDA does not review their safety, effectiveness or quality before marketing. Approval of a branded medicine or an ingredient for a particular indication does not establish approval, equivalence or effectiveness of a compounded program. Your clinician must consider approved alternatives and applicable compounding requirements.

Eligibility, pharmacy and availability

Availability depends on the patient’s state, clinician eligibility requirements, exact formulation and lawful pharmacy fulfillment. Pharmacy identity, prescribing pathway, storage, delivery and support arrangements must be verified before enrollment. No currently unverified pharmacy partnership or delivery promise is represented.

Safety and follow-up

Discuss adverse effects, allergies, interactions, reproductive or pregnancy considerations and monitoring with your clinician. Individual instructions and informed consent must be provided before treatment. Outcomes vary; no program guarantees healing, weight loss, performance gains, age reversal or another result. Do not use marketing information to self-dose or replace appropriate medical care.

Program-specific considerations

Tirzepatide

Tirzepatide is not appropriate for everyone. Your clinician must review medical history, other medications, pregnancy considerations and product-specific risks. Vial contents are not weekly doses. A compounded formulation is not an FDA-approved branded medication.

Program treatment information ↗

PROMETHEUS

Intended program goals are not established outcomes for this formulation. Individual clinical review, verified formulation and lawful pharmacy availability are required. No dosing instructions are provided here.

Program treatment information ↗

HYPNOS

Intended program goals are not established outcomes for this formulation. Individual clinical review, verified formulation and lawful pharmacy availability are required. No dosing instructions are provided here.

Program treatment information ↗

FOUNTAIN OF YOUTH

Intended program goals are not established outcomes for this formulation. Individual clinical review, verified formulation and lawful pharmacy availability are required. No dosing instructions are provided here.

Program treatment information ↗

APEX

Intended program goals are not established outcomes for this formulation. Individual clinical review, verified formulation and lawful pharmacy availability are required. No dosing instructions are provided here.

Program treatment information ↗

Zinc + Copper Hair Dropper

Intended program goals are not established outcomes for this formulation. Individual clinical review, verified formulation and lawful pharmacy availability are required. No dosing instructions are provided here.

Program treatment information ↗

Copper + Finasteride

Topical finasteride is not FDA-approved. Systemic absorption and adverse effects are possible. A clinician must discuss reproductive risks, handling and suitability before treatment.

Program treatment information ↗

Tesamorelin

The intended body-composition discussion does not establish benefit for general weight loss or healthy aging. Any proposed use requires clinical review, product-specific risk information and consideration of approved alternatives.

Program treatment information ↗

Copper + BPC + KPV — 5 mg

Human safety information for these compounded ingredients is limited. FDA reports no identified human exposure data for KPV drug products. Skin irritation, individual suitability and lawful compounding availability require clinical and pharmacy review; this is not a proven anti-aging treatment.

Program treatment information ↗

Fees and consent

Peptide and weight-management prices include clinical consultation, medication, fulfillment and injection supplies. Treatment requires clinical approval. Topical inclusions are listed separately. Treatment orders do not automatically renew. Laboratory testing is not included; any clinically required testing cost is disclosed before you proceed. Payment is collected after approval and before pharmacy fulfillment; no treatment-order charge applies when treatment is not prescribed. See payment questions and program terms.

Sources and further reading

This website does not replace patient-specific informed consent, prescribing information or the clinician’s required disclosures. Final clinical and legal review remains a launch requirement.

Your next chapter
Starts with a conversation
Start Evaluation